Company Profile

Via Therapeutics LLC
Profile last edited on: 4/19/2023      CAGE: 7CLS7      UEI: YHRZATLXKL46

Business Identifier: Novel drug delivery technologies
Year Founded
2014
First Award
2018
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

11113 Alison Parke Trail
Austin, TX 78750
   (512) 484-4335
   inquiry@alphavektor.com
   www.alphavektor.com
Location: Single
Congr. District: 37
County: Williamson

Public Profile

Describing themselves as focused on making molecules work through the firm's novel drug delivery technologies (viae), it is diffiuclt to know what this entity is actually about - firm's name is different from indicated website name which - in turn - lists some of the principals (with photos and bios) Speciifc description of firm reads as follows": "AlphaVektor is a pharmaceutical consulting group specializing in helping companies to progress their drug development programs efficiently and effectively. Our team of senior scientists, managers and engineers work with large companies, as well as start-up enterprises, proficiently guiding programs to success. We built our reputation by identifying and implementing pragmatic solutions to challenging technical and operational problems spanning all phases of product development and industrialization. Our experience and expertise in the operational, technical and managerial aspects of pharmaceutical product development and commercialization enables us to deliver robust, regulatory-compliant, cost-conscious solutions to our clientsÂ’ most complex challenges. Our single purpose: Guiding your Project to Success. Let's get started by discussing your needs and challenges"

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Key People / Management

  Ashlee D Brunaugh -- Senior Research Scientist

  John Joseph Koleng

  Stephen C Lermer

  Hugh David Smyth

  Zachary N Warnken -- Director, Pharmaceutical Development

  Robert O Williams